STAT March 15, 2024
Thiago Arzua

Scientists are taught early in our training that criticism is a fundamental part of the job. What we are not usually trained to navigate, however, is public backlash, which is exactly what followed the publication of the comprehensive genomic sequencing results from the All of Us Research Program. The study aims to add the genomic information of 1 million volunteers from normally underrepresented genetic backgrounds to datasets that have been mostly constituted by people of European descent.

The publication faced public criticism almost instantaneously. At the heart of the matter is how the study presented the diversity of race and ethnicity in their dataset. It gets a little technical, but it focuses on the fact that the researchers used a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine, Survey / Study, Trends
Navigating the Complexities of Payment for Genetic Testing
An NIH Genetics Study Targets a Long-Standing Challenge: Diversity
Karius Secures $100M to Expand Non-Invasive Pathogen Blood Test
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
BioAro Announces Real Time DNA Decoding Technology

Share This Article